RGEN

Repligen

118.91

1.84+1.57%

After Hours: 118.91 0.00 0.00%16:10 08/01 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE115.23/117.07

TODAY RANGE113.43-118.99

VOL941.49K

MARKET CAP6.68B

52 WEEK RANGE102.97-182.52

AVG VOL (3M)837.63K

% TURNOVER1.68%

TURNOVER--

P/E (TTM)-476.2115

% RANGE4.75%

EPS(TTM)-0.2497

P/E(FORWARD)132.12

P/B3.365

BVPS35.34

DIVIDEND--

P/S10.51

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP6.24B

SHARES OUTSTANDING56.18M

NEXT EARNINGS11/10-11/14

FREE FLOAT52.45M

LOT SIZE1

EX-DATE--

News

Press Releases

Financial Reports

Profile

Seeking Alpha·1d ago
Repligen partners with Novasign to use ML in filtration systems
TipRanks·1d ago
Repligen announces strategic partnership with Novasign
Reuters·1d ago
REPLIGEN: WILL INVEST IN NOVASIGN TO HELP SCALE AND EXPAND OPERATIONS
TipRanks·1d ago
Repligen’s Strong Market Position and Growth Prospects Justify Buy Rating
TipRanks·2d ago
Repligen’s Earnings Call Highlights Robust Growth
TipRanks·2d ago
Wells Fargo Sticks to Their Buy Rating for Repligen (RGEN)
TipRanks·2d ago
Repligen (RGEN) Gets a Hold from Canaccord Genuity
Dow Jones·2d ago
Repligen Price Target Raised to $204.00/Share From $193.00 by RBC Capital
Dow Jones·2d ago
Repligen Is Maintained at Outperform by RBC Capital
Benzinga·2d ago
RBC Capital Maintains Outperform on Repligen, Raises Price Target to $204
TipRanks·2d ago
RBC Capital Keeps Their Buy Rating on Repligen (RGEN)
Dow Jones·2d ago
Repligen Is Maintained at Overweight by Wells Fargo
Dow Jones·2d ago
Repligen Price Target Cut to $175.00/Share From $180.00 by Wells Fargo
Benzinga·2d ago
Wells Fargo Maintains Overweight on Repligen, Lowers Price Target to $175
TipRanks·2d ago
Stifel Nicolaus Sticks to Its Buy Rating for Repligen (RGEN)

Same Industry

Name/Symbol

Change%

Price

Repligen

RGEN

+1.57%

118.91

Atrion Corp

ATRI

0.00%

459.92

IDEXX Laboratories

IDXX

+0.23%

535.54

Cencora Inc.

COR

+0.79%

288.35

Teleflex Inc

TFX

-3.02%

115.89

Stryker Corp

SYK

-3.80%

377.79

West Pharm Svcs

WST

0.00%

239.26

Ufp Technologies

UFPT

+0.08%

226.57

Shockwave Medical, Inc.

SWAV

0.00%

334.75

Cooper

COO

+0.25%

70.87

Becton Dickinson & Co

BDX

-1.05%

176.37

Becton Dickinson And Co

BDXB

48.16

Utah Med Prods

UTMD

-1.17%

54.95

Align Technology Inc

ALGN

+5.82%

136.52

Henry Schein

HSIC

+0.49%

67.98

Ge Healthcare Technologies Inc

GEHC

-2.06%

69.85

Abbott Labs

ABT

+0.87%

127.29

Conmed Corp

CNMD

+2.23%

52.29

Medtronic

MDT

-1.00%

89.34

Zimmer Biomet

ZBH

-1.12%

90.62

BECTON DICKINSON

BDXA

0.0000

FAQ

Fee Schedule Open Account Deposit & Withdrawal Trading

Terms & Conditions

Client Agreement Privacy Policy Data Disclaimer Security Tips

About Webull

About us Webull Promotions Contact information Announcements

Contact Number : +852 3852 8500Service Email : service@webull.hkBusiness Cooperation : marketinghk@webull.hk

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.

Language

English